Perceiva sirolimus: Completed Phase II enrollment

MacuSight completed enrollment of 131 patients in the double-blind, placebo-controlled, dose-ranging, U.S. Phase II DIAMOND trial evaluating 3 dosages of subconjunctivally injected Perceiva given at b...